Reports continued progress in the evaluation of assets for potential in-licensing and development in the areas of oncology and rare disease - - New data from pilot ...

UBS Asset Management Americas sharply increased its Regeneron stake by 30.1%, snapping up 226,952 additional shares in Q4.

Sun Pharmaceutical Industries Ltd. posted a mixed fourth quarter on Thursday and announced a softer-than-expected financial ...

Morgan Stanley maintained an 'overweight' rating on ITC Ltd. with a target price of Rs 500, citing strong topline growth ...

ProShare Advisors LLC increased its stake in Regeneron Pharmaceuticals by a hefty 21.7% in Q4, now owning 146,135 shares ...

CLEVELAND (AP) — CLEVELAND (AP) — Sifco Industries Inc. (SIF) on Tuesday reported a loss of $443,000 in its fiscal fourth quarter. The Cleveland-based company said it had a loss of 8 cents per share.

Wall Street closed mixed on Tuesday as investors digested a weaker-than-expected US inflation report that revived hopes of interest rate cuts later this year.

We recently compiled a list of the 10 Jim Cramer Stocks with Huge Upside Potential. In this article, we are going to take a look at where Regeneron Pharmaceuticals, Inc.

Looking back on immuno-oncology stocks’ Q4 earnings, we examine this quarter’s best and worst performers, including Regeneron (NASDAQ:REGN) and its peers. Over the next few years, immuno ...

BioLineRx Ltd. , a development stage biopharmaceutical company pursuing life-changing therapies in oncology and rare diseases, today reported its unaudited financial results for the quarter ended ...